Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety of Sumanirole in Parkinson's Disease
NCT00036205Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Aug 2000
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of sumanirole in Parkinson's disease (PD), sponsored by Pfizer. Started Aug 2000; status: terminated.
02
Drugs
sumanirole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00036205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00036205.